{
    "2021-06-24": [
        [
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Is One Of The Biggest Pharma Companies, But Is It A Buy Right Now?",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "biggest",
                        "pharma",
                        "buy"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Exercises Right to Acquire TeneoOne and Lead Asset TNB-383B for the Potential Treatment of Relapsed or Refractory Multiple Myeloma",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "acquire",
                        "TeneoOne",
                        "TNB-383B",
                        "treatment",
                        "multiple myeloma"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}